In the case of BRCA1-associated breast cancer, ID4 amplification, like TP53 mutation, may be permissive for subsequent BRCA1 LOH which is otherwise lethal [69], explaining the high frequency of ID4 amplification in familial cancers. This evidence concerns the gene TP53 and hereditary cancer.